Commentary: APP as a Mediator of the Synapse Pathology in Alzheimer's Disease

Commentary: APP as a Mediator of the Synapse Pathology in Alzheimer's Disease

Bibliographic Details
Main Authors:	An Schreurs, Amira Latif-Hernandez, Alice Uwineza
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2018-05-01
Series:	Frontiers in Cellular Neuroscience
Subjects:	Alzheimer's disease amyloid-beta amyloid precursor protein electrophysiology oligomers synaptic plasticity
Online Access:	https://www.frontiersin.org/article/10.3389/fncel.2018.00150/full

Similar Items

Synapses, synaptic activity and intraneuronal Aβ in Alzheimer's disease
by: Davide Tampellini
Published: (2010-05-01)

Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer’s disease
by: Shaomin Li, et al.
Published: (2018-11-01)

Glycines from the APP GXXXG/GXXXA transmembrane motifs promote formation of pathogenic Aβ oligomers in cells
by: Marie eDecock, et al.
Published: (2016-05-01)

The Small Molecule GAL-201 Efficiently Detoxifies Soluble Amyloid β Oligomers: New Approach towards Oral Disease-Modifying Treatment of Alzheimer’s Disease
by: Hermann Russ, et al.
Published: (2022-05-01)

Differential Effect of Amyloid Beta1-40 on Short-term and Long-term Plasticity in Dentate Gyrus of a Rat Model of Alzheimer Disease
by: Javad Fahanik-Babaei, et al.
Published: (2020-07-01)

L-type voltage-gated calcium channel blockade with isradipine as a therapeutic strategy for Alzheimer's disease
by: Thimmappa S. Anekonda, et al.
Published: (2011-01-01)

ACU193: An Immunotherapeutic Poised to Test the Amyloid β Oligomer Hypothesis of Alzheimer’s Disease
by: Grant A. Krafft, et al.
Published: (2022-04-01)

Prominent amyloid plaque pathology and cerebral amyloid angiopathy in APP V717I (London) carrier – phenotypic variability in autosomal dominant Alzheimer’s disease
by: Grace M. Lloyd, et al.
Published: (2020-03-01)

Excessive/Aberrant and Maladaptive Synaptic Plasticity: A Hypothesis for the Pathogenesis of Alzheimer’s Disease
by: Shigeki Kawabata
Published: (2022-07-01)

Re-Arranging the Puzzle between the Amyloid-Beta and Tau Pathology: An APP-Centric Approach
by: Florence Haut, et al.
Published: (2023-12-01)

Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer’s Disease
by: Tapan Behl, et al.
Published: (2020-10-01)

APP and APLP2 interact with the synaptic release machinery and facilitate transmitter release at hippocampal synapses
by: Tomas Fanutza, et al.
Published: (2015-11-01)

Plaque-Associated Oligomeric Amyloid-Beta Drives Early Synaptotoxicity in APP/PS1 Mice Hippocampus: Ultrastructural Pathology Analysis
by: Raquel Sanchez-Varo, et al.
Published: (2021-11-01)

Differential effects of familial Alzheimer’s disease-causing mutations on amyloid precursor protein (APP) trafficking, proteolytic conversion, and synaptogenic activity
by: Sandra Schilling, et al.
Published: (2023-06-01)

Brain injury, neuroinflammation and Alzheimer’s disease
by: Joshua eBreunig, et al.
Published: (2013-07-01)

Amyloidosis in Alzheimer’s Disease: Pathogeny, Etiology, and Related Therapeutic Directions
by: Chen Ma, et al.
Published: (2022-02-01)

Altered synaptic plasticity at hippocampal CA1–CA3 synapses in Alzheimer's disease: integration of amyloid precursor protein intracellular domain and amyloid beta effects into computational models
by: Justinas J. Dainauskas, et al.
Published: (2023-12-01)

LTP and memory impairment caused by extracellular Aβ and Tau oligomers is APP-dependent
by: Daniela Puzzo, et al.
Published: (2017-07-01)

Recent advancements toward therapeutic vaccines against Alzheimer’s disease
by: Krystal Herline, et al.
Published: (2018-08-01)

Toxic oligomer species of amyloid-β in Alzheimer's disease, a timing issue
by: Sylvain E. Lesne
Published: (2014-11-01)

Dreaming of a New World Where Alzheimer’s Is a Treatable Disorder
by: Marcella Catania, et al.
Published: (2019-11-01)

Abeta(1–40)-induced secretion of matrix metalloproteinase-9 results in sAPPα release by association with cell surface APP
by: Argiris A. Talamagas, et al.
Published: (2007-12-01)

Non-canonical soluble amyloid-beta aggregates and plaque buffering: controversies and future directions for target discovery in Alzheimer’s disease
by: David L. Brody, et al.
Published: (2017-08-01)

Current advances in the treatment of Alzheimer's disease: focused on considerations targeting Aβ and tau
by: Hong-Qi Yang, et al.
Published: (2012-10-01)

Review Paper: Tau Pathology of Alzheimer Disease: Possible Role of Sleep Deprivation
by: Nahid Ahmadian, et al.
Published: (2018-09-01)

Golgi Fragmentation in Alzheimer’s Disease
by: Gunjan eJoshi, et al.
Published: (2015-09-01)

Signaling abnormality leading to excessive/aberrant synaptic plasticity in Alzheimer's disease
by: Shigeki Kawabata
Published: (2022-10-01)

Exercise for the prevention of Alzheimer's disease: Multiple pathways to promote non-amyloidogenic AβPP processing
by: Richard J. Elsworthy, et al.
Published: (2022-09-01)

Improved NMDA Receptor Activation by the Secreted Amyloid-Protein Precursor-α in Healthy Aging: A Role for D-Serine?
by: Jean-Marie Billard, et al.
Published: (2022-12-01)

Expression of endogenous mouse APP modulates β-amyloid deposition in hAPP-transgenic mice
by: Johannes Steffen, et al.
Published: (2017-06-01)

Genetic Inactivation of Free Fatty Acid Receptor 3 Impedes Behavioral Deficits and Pathological Hallmarks in the APP<sub>swe</sub> Alzheimer’s Disease Mouse Model
by: Marta Zamarbide, et al.
Published: (2022-03-01)

Amyloid Beta in Aging and Alzheimer’s Disease
by: Ujala Sehar, et al.
Published: (2022-10-01)

Synaptic activity and Alzheimer’s disease: a critical update
by: Davide eTampellini
Published: (2015-11-01)

Editorial: Beta-Amyloid oligomer specific treatments for Alzheimer's disease
by: Heinz Hillen
Published: (2023-01-01)

Potential Implications of miRNAs in the Pathogenesis, Diagnosis, and Therapeutics of Alzheimer’s Disease
by: Long Wang, et al.
Published: (2023-11-01)

The Role of MicroRNAs in Aβ Deposition and Tau Phosphorylation in Alzheimer’s Disease
by: Juanjuan Zhao, et al.
Published: (2017-07-01)

Oligomerization and Conformational Change Turn Monomeric β-Amyloid and Tau Proteins Toxic: Their Role in Alzheimer’s Pathogenesis
by: Botond Penke, et al.
Published: (2020-04-01)

Structural analysis and modeling comparison of primates' amyloid BA4 protein /
by: Fahimeh Jalali, 1987-, et al.
Published: (2013)

Structural analysis and modeling comparison of primates' amyloid BA4 protein [electronic resource] /
by: Fahimeh Jalali, 1987-
Published: (2013)

JNK regulates APP cleavage and degradation in a model of Alzheimer's disease
by: Alessio Colombo, et al.
Published: (2009-03-01)